TACTILE SYSTEMS TECHNOLOGY INC TCMD

Latest FY: 2025 Healthcare Medical Devices
Market Price $24.22
Market Cap $535.26M
P/E Ratio 29.54
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑12.5% YoY
$329.52M
3-Yr CAGR: 10.1%
Net Income ↑12.5% YoY
$19.09M
Net Margin: 5.8%
Free Cash Flow ↑5.7% YoY
$40.43M
FCF Yield: 7.55%
EPS (Diluted) ↑17.1% YoY
$0.82
Basic: $0.83
Return on Equity Efficiency
8.7%
ROA: 236.6%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TCMD)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $84.5M $61.6M $2.9M $0.15 $7.0M $6.3M
FY 2017 $109.3M +29.3% $80.3M $5.9M +103.4% $0.31 +106.7% $4.2M $0.4M -92.9%
FY 2018 $143.8M +31.5% $102.3M $6.6M +13.1% $0.34 +9.7% $9.0M $4.8M +978.7%
FY 2019 $189.5M +31.8% $134.2M $11.0M +65.7% $0.56 +64.7% $2.5M $-2.9M -161.0%
FY 2020 $187.1M -1.2% $132.8M $-0.6M -105.7% $-0.03 -105.4% $2.8M $0.7M +125.0%
FY 2021 $208.1M +11.2% $148.2M $-11.8M -1,805.0% $-0.60 -1,900.0% $2.6M $0.5M -28.2%
FY 2022 $246.8M +18.6% $176.0M $-17.9M -51.3% $-0.89 -48.3% $5.2M $3.4M +549.4%
FY 2023 $274.4M +11.2% $195.1M $28.5M +259.6% $1.23 +238.2% $35.9M $33.5M +877.9%
FY 2024 $293.0M +6.8% $216.7M $17.0M -40.5% $0.70 -43.1% $40.7M $38.3M +14.1%
FY 2025 $329.5M +12.5% $250.1M $19.1M +12.5% $0.82 +17.1% $42.8M $40.4M +5.7%
$

Valuation

Market Price $24.22
Market Cap $535.26M
Enterprise Value $451.81M
P/E Ratio 29.54
P/B Ratio 2.50
FCF Yield 7.55%
Dividend Yield N/A
Shares Outstanding 22,556,300
%

Profitability & Margins

Gross Margin 75.91%
Operating Margin 8.89%
Net Margin 5.79%
Return on Equity (ROE) 8.72%
Return on Assets (ROA) 236.62%
Asset Turnover 40.85x
Revenue 3-Yr CAGR 10.12%
🛡️

Financial Health & Liquidity

Current Ratio 0.95
Cash Ratio 9.78
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $83.45M
Total Debt N/A
Book Value / Share $9.70
💧

Cash Flow Efficiency

Operating Cash Flow $42.81M
Capital Expenditures (CapEx) $2.38M
Free Cash Flow $40.43M
OCF / Revenue 12.99%
FCF / Revenue 12.27%
FCF 3-Yr CAGR 127.61%
🏷️

Per Share Metrics

EPS (Diluted) $0.82
EPS (Basic) $0.83
Dividends / Share N/A
Book Value / Share $9.70
EPS YoY Growth 17.14%
🏛️

Balance Sheet (FY 2025)

Total Assets $8.07M
Total Liabilities $8.53M
Stockholders' Equity $218.90M
Current Assets $8.07M
Current Liabilities $8.53M